6969:HKEXSmoore International Holdings Limited Analysis
Data as of 2026-03-15 - not real-time
NT$28.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
TRANSCENE Co. Ltd is trading well below its discounted cash‑flow estimate, with the market price around 28 while the DCF fair value is near 46. The stock sits beneath its 20‑day, 50‑day and 200‑day moving averages (30.6, 31.4 and 36.0 respectively), confirming a pronounced bearish technical backdrop. Momentum indicators are weak – the RSI hovers near the low‑30s and the MACD line remains under the signal, producing a bearish histogram. Despite the technical headwinds, the company posted an impressive 58% revenue growth year‑over‑year and generates positive operating cash flow, suggesting a solid top‑line trajectory. However, profitability is fragile with a trailing EPS of –0.39, a negative net margin and a staggering debt‑to‑equity ratio above 220, which raises concerns about financial stability. Volatility is high (over 40% 30‑day) and the max drawdown approaches 47%, indicating that price swings could be severe.
The market sentiment leans toward greed, as reflected by a fear‑and‑greed index in the high‑70s, but the lack of dividend and the heavy debt load temper enthusiasm. In the short run the price is testing a support near 27.75, while the next resistance lies around 32.8, limiting upside potential unless a clear catalyst emerges. Over the medium horizon, the DCF upside and strong revenue growth could support a stabilization, provided the company can curb losses and improve its balance sheet. Long‑term investors may view the current discount as an entry point if the firm can translate its cash‑generating capacity into sustainable earnings and deleverage its capital structure.
The market sentiment leans toward greed, as reflected by a fear‑and‑greed index in the high‑70s, but the lack of dividend and the heavy debt load temper enthusiasm. In the short run the price is testing a support near 27.75, while the next resistance lies around 32.8, limiting upside potential unless a clear catalyst emerges. Over the medium horizon, the DCF upside and strong revenue growth could support a stabilization, provided the company can curb losses and improve its balance sheet. Long‑term investors may view the current discount as an entry point if the firm can translate its cash‑generating capacity into sustainable earnings and deleverage its capital structure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below all major moving averages
- negative earnings and high debt load
- increasing volatility and bearish MACD
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- strong revenue growth and positive operating cash flow
- substantial discount to DCF fair value
- ongoing balance‑sheet weakness
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- potential upside if profitability improves
- significant DCF upside cushion
- market sentiment currently in a greedy phase
Key Metrics & Analysis
Financial Health
Revenue Growth58.10%
Profit Margin-0.99%
ROE-1.09%
ROA1.13%
Debt/Equity221.83
P/B Ratio3.7
Op. Cash FlowNT$115.5M
Free Cash FlowNT$65.0M
Industry P/E29.1
Technical Analysis
TrendBearish
RSI32.7
SupportNT$27.75
ResistanceNT$32.80
MA 20NT$30.60
MA 50NT$31.37
MA 200NT$35.96
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueNT$46.26
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.80
Volatility43.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.